Live Breaking News & Updates on Sudhir chandana

Stay informed with the latest breaking news from Sudhir chandana on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Sudhir chandana and stay connected to the pulse of your community

2-DG drug initially developed for cancer treatment, lures coronavirus by looking like glucose: Former DRDO scientist | India News

India News: NEW DELHI: Defence Research and Development Organisation’s drug 2-deoxy-D-glucose (2-DG), which has been granted permission by drug regulator DCGI for.

Hyderabad , Andhra-pradesh , India , Sudhir-chandana , G-satheesh-reddy , Anant-narayana-bhatt , Ravi-kumar , Praveen-chandra , Dr-reddy-lab , Centre-for-cellular , Institute-of-nuclear-medicine , Development-organisation

2-DG drug initially developed for cancer treatment, lures coronavirus by looking like glucose: Former DRDO scientist | India News

2-DG drug initially developed for cancer treatment, lures coronavirus by looking like glucose: Former DRDO scientist | India News
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.

Hyderabad , Andhra-pradesh , India , Sudhir-chandana , G-satheesh-reddy , Anant-narayana-bhatt , Ravi-kumar , Praveen-chandra , Dr-reddy-lab , Centre-for-cellular , Institute-of-nuclear-medicine , Development-organisation

DRDO invites EoIs for 2-DG technology transfer for bulk production

Last date to submit EoI applications through email is June 17. EoI submitted by industries will be scrutinised by a Technical Assessment Committe, a DRDO statement said

India , Sudhir-chandana , Technical-assessment-committee , Development-organisation , Defence-research , First-come-served-basis , Active-pharmaceutical-ingredient , Drug-licencing-authorities , Good-manufacturing-practices , Drdo-invites-eois , 2-dg-technology-transfer , Bulk-production

DRDO's anti-covid drug 2-DG launched; checkout efficacy, price, dosage

DRDO's anti-covid drug 2-DG launched; checkout efficacy, price, dosage
Anti-Covid oral drug has been developed by DRDO's leading laboratory -- Institute of Nuclear Medicine and Allied Sciences in collaboration with Dr Reddy's Laboratories
BusinessToday.In | May 17, 2021 | Updated 12:57 IST
Defence minister Rajnath Singh and health minister Harsh Vardhan. Photo Credit: ANI
Union defence minister Rajnath Singh today released the first batch of the anti-Covid-19 drug, 2-deoxy-D-glucose (2-DG), which has been granted emergency approval by the Drug Controller General of India (DCGI). The anti-Covid oral drug has been developed by the Defence Research and Development Organisation's (DRDO's) leading laboratory- Institute of Nuclear Medicine and Allied Sciences (INMAS) in collaboration with Dr Reddy's Laboratories.

India , Bharat , Sudhir-chandna , Rajnath-singh , Sudhir-chandana , Institute-of-nuclear-medicine , Development-organisation , Defence-research , Drug-controller-general , Nuclear-medicine , Allied-sciences , Bharat-biotech

DRDO 2-DG Medicine: Efficacy, Price in India, Availability, All You Need To Know About New Anti Covid Drug - 2डीजी दवा डीआरडीओ: कोरोना के खिलाफ कैसे काम करती है? भारत में दाम, डोज और उपलब्‍धता की हर जानकारी

DRDO 2-DG Medicine: Efficacy, Price in India, Availability, All You Need To Know About New Anti Covid Drug - 2डीजी दवा डीआरडीओ: कोरोना के खिलाफ कैसे काम करती है? भारत में दाम, डोज और उपलब्‍धता की हर जानकारी
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.

Hyderabad , Andhra-pradesh , India , Rajnath-singh , Sudhir-chandana , Morea-defense-research , Development-organisation , Secretary-rajnath-singh , Secretary-harsha , Start-corona , Defense-research , Allied-sciences

जानें DRDO द्वारा विकसित कोरोना की दवाई 2-DG से क्यों है उम्मीद

जानें DRDO द्वारा विकसित कोरोना की दवाई 2-DG से क्यों है उम्मीद
loktej.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from loktej.com Daily Mail and Mail on Sunday newspapers.

Delhi , India , Rajnath-singh , Sudhir-chandana , Randeep-guleria , Satish-reddy , Advanced-corona , Health-secretary , Secretary-rajnath-singh , Clinical-trial , Recovery-view

Game changer anti-corona drug 2-DG of DRDO all that you 2-DG know, 2-deoxy-D-glucose, DGCI approves for emergency use against COVID 19 | वायरस की एनर्जी काट देती है DRDO की दवा; जानिए बाजार में कब तक आएगी और क्या होगी इसकी कीमत

Game changer anti-corona drug 2-DG of DRDO all that you 2-DG know, 2-deoxy-D-glucose, DGCI approves for emergency use against COVID 19 | वायरस की एनर्जी काट देती है DRDO की दवा; जानिए बाजार में कब तक आएगी और क्या होगी इसकी कीमत
bhaskar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bhaskar.com Daily Mail and Mail on Sunday newspapers.

India , Sudhir-chandana , Reddy-lab , Reddy-laba-it , Nuclear-medicine-end-allied-sciences , Pharma-the-company , More-market , Her-country , Clinical-trial , Project-director , New-corona , Properties-contain

All you need to know about DRDO's new anti-COVID-19 drug 2-DG

All you need to know about DRDO's new anti-COVID-19 drug 2-DG
The anti-Covid oral drug has been developed by the Defence Research and Development Organisation's (DRDO's) leading laboratory- Institute of Nuclear Medicine and Allied Sciences (INMAS) in collaboration with Dr Reddy's Laboratories
BusinessToday.In | May 10, 2021 | Updated 15:01 IST
The 2-DG drug is expected to help hospitalised COVID-19 patients and reduce their supplemental oxygen dependence
DRDO's new anti-Covid oral drug, 2-deoxy-D-glucose (2-DG), was recently granted emergency use approval by the Drug Controller General of India (DCGI) as an adjunct therapy in moderate cases of COVID-19. The 2-DG drug is expected to help hospitalised COVID-19 patients and reduce their supplemental oxygen dependence.

India , Sudhir-chandana , Institute-of-nuclear-medicine , Development-organisation , Defence-research , Drug-controller-general , Nuclear-medicine , Allied-sciences , இந்தியா , நிறுவனம்-ஆஃப்-அணு-மருந்து , வளர்ச்சி-ஆர்கநைஸேஶந் , பாதுகாப்பு-ஆராய்ச்சி

DRDO's new anti covid drug reduces dependence in oxygen dgtl

DRDO's new anti covid drug reduces dependence in oxygen dgtl
anandabazar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from anandabazar.com Daily Mail and Mail on Sunday newspapers.

India , Sudhir-chandana , Agencya-clinical , இந்தியா ,

DCGI approves anti-COVID drug developed by DRDO | कोरोना के इलाज के लिए एक और दवा को मंजूरी, सरकार ने इमरजेंसी यूज की दी इजाजत

DCGI approves anti-COVID drug developed by DRDO | कोरोना के इलाज के लिए एक और दवा को मंजूरी, सरकार ने इमरजेंसी यूज की दी इजाजत
india.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from india.com Daily Mail and Mail on Sunday newspapers.

Delhi , India , Hyderabad , Andhra-pradesh , New-delhi , Sudhir-chandana , Hyderabad-center , Energy-production , Nuclear-medicine-end-allied-sciences , Dr-reddy-lab , Emergency-use , End-biology